Ligand validation:5WB7

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5WB7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WB7_NAG_C_603	41%	81%	0.177	0.894	0.18	0.62	-	-	0	0	100%	0.9333
5WB7_NAG_B_602	21%	85%	0.194	0.801	0.29	0.44	-	-	0	0	100%	0.9333
5WB7_NAG_A_3206	17%	74%	0.187	0.763	0.28	0.72	-	-	0	0	100%	0.9333
5WB7_NAG_B_601	13%	78%	0.25	0.792	0.28	0.6	-	-	0	0	100%	0.9333
5WB7_NAG_A_3201	8%	62%	0.253	0.724	0.33	1.09	-	2	0	0	100%	0.9333
5WB7_NAG_D_601	6%	67%	0.281	0.724	0.61	0.67	1	1	0	0	100%	0.9333
5WB7_NAG_A_3207	1%	61%	0.253	0.402	0.28	1.2	-	2	0	0	100%	0.9333
3B2V_NAG_A_3891	51%	13%	0.143	0.897	0.79	3.06	-	6	2	0	100%	0.9333
7LFS_NAG_A_3301	46%	83%	0.143	0.878	0.34	0.43	-	-	2	0	100%	0.9333
5XWD_NAG_A_711	42%	68%	0.158	0.878	0.52	0.69	-	-	0	0	100%	0.9333
4KRP_NAG_A_703	42%	80%	0.169	0.889	0.3	0.54	-	-	1	0	100%	0.9333
6ARU_NAG_A_710	39%	49%	0.161	0.868	0.6	1.36	-	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.